MEP40708A - Inhalative solution formulation containing a tiotropium salt - Google Patents

Inhalative solution formulation containing a tiotropium salt

Info

Publication number
MEP40708A
MEP40708A MEP-407/08A MEP40708A MEP40708A ME P40708 A MEP40708 A ME P40708A ME P40708 A MEP40708 A ME P40708A ME P40708 A MEP40708 A ME P40708A
Authority
ME
Montenegro
Prior art keywords
formulation containing
solution formulation
tiotropium salt
inhalative solution
inhalative
Prior art date
Application number
MEP-407/08A
Other languages
Bosnian (bs)
Croatian (hr)
Inventor
Karin Drechsel
Barbara Niklaus-Humke
Christel Schmelzer
Petra Barth
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP40708(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MEP40708A publication Critical patent/MEP40708A/en
Publication of ME00242B publication Critical patent/ME00242B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Abstract

Predmetni pronalazak se odnosi na formulaciju za inhalaciju bez pogonskog gasa sa tiotropijum bromidom odn. tiotropijum bromid monohidratom koji je rastvoren u vodi ili u smješi vode i etanola i na aerosol za inhalaciju bez pogonskog gasa koji se dobija od nje.The present invention relates to a formulation for inhalation without propellant gas with tiotropium bromide or. tiotropium bromide monohydrate dissolved in water or in a mixture of water and ethanol and on an aerosol for inhalation without propellant gas obtained therefrom.

MEP-2008-407A 2000-10-31 2001-10-24 Inhalative solution formulation containing a tiotropium salt ME00242B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10054042 2000-10-31
YU33103A YU33103A (en) 2000-10-31 2001-10-24 Inhalative solution formulation containing a tiotropium salt
PCT/EP2001/012296 WO2002036591A2 (en) 2000-10-31 2001-10-24 Inhalative solution formulation containing a tiotropium salt

Publications (2)

Publication Number Publication Date
MEP40708A true MEP40708A (en) 2011-02-10
ME00242B ME00242B (en) 2011-05-10

Family

ID=7661727

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-407A ME00242B (en) 2000-10-31 2001-10-24 Inhalative solution formulation containing a tiotropium salt

Country Status (33)

Country Link
EP (1) EP1335729A2 (en)
JP (1) JP4559703B2 (en)
KR (1) KR100983208B1 (en)
CN (1) CN1237970C (en)
AR (1) AR038765A1 (en)
AU (2) AU2174102A (en)
BG (1) BG66425B1 (en)
BR (1) BR0115016A (en)
CA (1) CA2427583C (en)
CZ (1) CZ305033B6 (en)
DE (1) DE10152369A1 (en)
EA (1) EA009068B1 (en)
EC (1) ECSP034570A (en)
EE (1) EE05343B1 (en)
HK (1) HK1060569A1 (en)
HR (1) HRP20030337A2 (en)
HU (1) HUP0301377A3 (en)
IL (2) IL155676A0 (en)
ME (1) ME00242B (en)
MX (1) MXPA03003750A (en)
MY (1) MY132777A (en)
NO (1) NO332524B1 (en)
NZ (1) NZ526024A (en)
PE (1) PE20020518A1 (en)
PL (1) PL361001A1 (en)
SA (1) SA01220503B1 (en)
SK (1) SK288031B6 (en)
TW (1) TWI296934B (en)
UA (1) UA76435C2 (en)
UY (1) UY26991A1 (en)
WO (1) WO2002036591A2 (en)
YU (1) YU33103A (en)
ZA (1) ZA200303045B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60114865T2 (en) 2000-04-28 2006-07-27 Kosan Biosciences, Inc., Hayward HETEROLOGIST PREPARATION OF POLYCETIDES
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
AU2004279438A1 (en) * 2003-10-09 2005-04-21 Inverseon, Inc. Methods for treating diseases and conditions with inverse agonists
SE0303269L (en) * 2003-12-03 2005-06-04 Microdrug Ag Medical product
CA2595791C (en) * 2005-03-16 2013-10-08 Meda Pharma Gmbh & Co. Kg The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
US20070274925A1 (en) * 2006-05-26 2007-11-29 Dey, L.P. Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
CN100446770C (en) * 2007-01-10 2008-12-31 上海现代药物制剂工程研究中心有限公司 Water aerosol containing beclomethasone dipropionate
TR200907237A2 (en) * 2009-09-23 2011-04-21 Bi̇lgi̇ç Mahmut Tiotropium dry powder combination
CN116173025A (en) * 2018-07-26 2023-05-30 四川海思科制药有限公司 Aerosol pharmaceutical composition containing glycopyrronium salt and indacaterol salt, and preparation method and application thereof
CN111971034A (en) * 2018-07-26 2020-11-20 四川海思科制药有限公司 Aerosol pharmaceutical composition containing glycopyrronium salt and preparation method and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE4203306A1 (en) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh ASTHMA OR PULMONAL AEROSOL PREPARATIONS WITH LECITHIN
DK0835098T3 (en) * 1995-06-27 2002-10-07 Boehringer Ingelheim Pharma Stable drug preparation to produce propellant-free aerosols
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
BR9709650A (en) * 1996-06-04 1999-08-10 Procter & Gamble Nasal aerosol containing an intransal steroid and an antihistamine
DE19653969A1 (en) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg New aqueous pharmaceutical preparation for the production of propellant-free aerosols
JPH10298107A (en) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd Pharmaceutical composition
DK1102579T3 (en) * 1998-08-04 2003-07-14 Jago Res Ag Medical aerosol formulations
DE19847968A1 (en) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit.

Also Published As

Publication number Publication date
CZ20031487A3 (en) 2003-09-17
YU33103A (en) 2006-05-25
AU2174102A (en) 2002-05-15
BR0115016A (en) 2005-05-03
SK5262003A3 (en) 2003-10-07
AU2002221741B2 (en) 2007-04-05
EE200300202A (en) 2003-10-15
CN1473044A (en) 2004-02-04
KR100983208B1 (en) 2010-09-20
CA2427583C (en) 2008-02-12
HUP0301377A2 (en) 2003-10-28
DE10152369A1 (en) 2002-05-08
NO332524B1 (en) 2012-10-08
PL361001A1 (en) 2004-09-20
CA2427583A1 (en) 2002-05-10
ME00242B (en) 2011-05-10
MXPA03003750A (en) 2004-10-15
EP1335729A2 (en) 2003-08-20
AR038765A1 (en) 2005-01-26
SK288031B6 (en) 2012-12-03
EA009068B1 (en) 2007-10-26
NO20031914L (en) 2003-06-23
NO20031914D0 (en) 2003-04-29
PE20020518A1 (en) 2002-07-12
MY132777A (en) 2007-10-31
NZ526024A (en) 2005-10-28
WO2002036591A3 (en) 2002-07-25
SA01220503B1 (en) 2007-03-10
HRP20030337A2 (en) 2005-04-30
BG107726A (en) 2004-11-30
HK1060569A1 (en) 2004-08-13
CZ305033B6 (en) 2015-04-08
IL155676A (en) 2012-05-31
UY26991A1 (en) 2002-06-20
UA76435C2 (en) 2006-08-15
ECSP034570A (en) 2003-06-25
IL155676A0 (en) 2003-11-23
WO2002036591A2 (en) 2002-05-10
TWI296934B (en) 2008-05-21
JP2004523482A (en) 2004-08-05
JP4559703B2 (en) 2010-10-13
KR20040010552A (en) 2004-01-31
EE05343B1 (en) 2010-10-15
BG66425B1 (en) 2014-04-30
ZA200303045B (en) 2004-04-22
EA200300483A1 (en) 2003-12-25
HUP0301377A3 (en) 2005-12-28
CN1237970C (en) 2006-01-25

Similar Documents

Publication Publication Date Title
MEP40708A (en) Inhalative solution formulation containing a tiotropium salt
CY1108137T1 (en) COMPOSITION FOR DOSAGE INHALATOR INHIBITOR USING HYDRO-FLUOR-ALKANIA AS PROMOTIONAL
EP1248612A4 (en) Novel compounds and compositions as protease inhibitors
NO20062877L (en) Stable liposome compositions comprising lipophilic amine-containing pharmaceutical agents
ECSP077402A (en) DERIVATIVES OF 2-AMIDO-4-PHENYLTIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
MEP40408A (en) Inhalative solution formulation containing a tiotropium salt
ECSP066541A (en) NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA
MXPA02012903A (en) Colchinol derivatives as angiogenesis inhibitors.
TW200531683A (en) Aryl- and heteroarylpiperidinecarboxylate derivatives, their preparation and their application in therapeutics
MY153023A (en) Tropane derivatives useful in therapy
CR8842A (en) DERIVATIVES OF PIRIDO-PIRIMIDINA, ITS PREPARATION, ITS APPLICATION IN THERAPEUTICS
CL2012001668A1 (en) Pharmaceutical composition comprising glycopyrronium bromide dissolved in a hydrofluoroalkane propellant and 5 to 25% ethanol, containing 0.005 and 1 µg / µl of 1m hydrochloric acid; method of filling an aerosol container with the pharmaceutical composition; use in epoc, among others.
EA200600528A1 (en) METHOD OF OBTAINING WATER SOLUBLE DITERPENES AND THEIR APPLICATION
MXPA03011480A (en) Aqueous cilostazol preparation for injection.
RS87904A (en) Aerosol formulation for inhalation comprising a tiotropium salt
DOP2001000268A (en) PIPERAZINE BRIDGE DERIVATIVES
NO20032371L (en) Makrolidsolvater
AR060072A1 (en) DOSING AEROSOLS FOR THE ADMINISTRATION OF PHARMACEUTICAL PREPARATIONS
HUP0201700A2 (en) Stable xylometazoline and oxymetazoline solutions, their use for producing pharmaceutical compositions and pharmaceutical compositions containing them
HN2001000021A (en) NEW DERIVATIVES OF AMETAS HETEROCICLICAS
ATE396177T1 (en) NEW CRYSTALLINE FORMS OF A FACTOR XA INHIBITOR
AR031720A1 (en) BENZIMIDAZOLES N-ALCOXIALQUIL SUBSTITUTED, PROCESS FOR THE PREPARATION, COMPOSITIONS, AND USE OF THESE COMPOUNDS TO PREPARE ANTIPARASITARY COMPOSITIONS
AR080047A1 (en) COMPOUNDS THAT RELEASE NITRIC OXIDE FOR THE TREATMENT OF PAIN
PT1150660E (en) EFFERVESCENT PHARMACEUTICAL FORM CONTAINING METAMIZOLE
ES2166306B1 (en) TENSIOACTIVE DISINFECTANT COMPOSITION.